Chilton Capital Management »

Mink Therapeutics shares owned by Chilton Capital Management

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Chilton Capital Management from 13F filings

Historical chart of Chilton Capital Management investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Chilton Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Chilton Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $331 309 1.07
2023-09-30 $339 309 1.10
2023-06-30 $648 309 2.10